Gail Boudreaux compensation by year
Elevance Health Summary Compensation Table · all 9 fiscal years held| Component | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Salary | $161,538 | $1,400,000 | $1,400,000 | $1,400,000 | $1,561,538 | $1,600,000 | $1,600,000 | $1,600,000 | $1,600,000 |
| Bonus | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock awards | $2,000,215 | $7,687,717 | $8,362,743 | $9,000,196 | $9,900,081 | $11,100,128 | $11,850,043 | $12,600,032 | $13,440,277 |
| Option awards | $0 | $2,562,332 | $2,787,303 | $2,999,847 | $3,299,986 | $3,699,929 | $3,950,036 | $4,199,989 | $4,199,765 |
| Non-equity incentive | $0 | $2,418,150 | $2,695,000 | $3,270,800 | $4,019,399 | $3,840,000 | $3,648,000 | $1,142,400 | $2,768,000 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| All other | $4,500 | $116,077 | $228,093 | $439,109 | $567,237 | $691,024 | $840,960 | $929,555 | $574,272 |
| Total | $2,166,253 | $14,184,276 | $15,473,139 | $17,109,952 | $19,348,241 | $20,931,081 | $21,889,039 | $20,471,976 | $22,582,314 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Elevance Health, Inc. DEF 14A filed March 27, 2026, accession 0001156039-26-000031, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Elevance Health, Inc. filed document, accession 0001156039-26-000031. Every figure is read from that document and cited to the page and table it appears in. Filed March 27, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 40,193 | $14,089,656 | — |
| RSU | 29,565 | $10,364,011 | — |
| Option | 10,794 | — | $469.03 |
| Option | 21,654 | — | $499.11 |
| Option | 40,429 | — | $395.50 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Elevance Health, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
2 Form 4 lines since the FY2025 proxy (filed March 27, 2026)current to 2026-11-06 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-07-17 | Purchase | — | 680 | $366.41 | 169,931 |
| 2026-07-17 | Purchase | — | 2,045 | $368.25 | 171,976 |
The 2 most recent of 2 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Change-in-control & termination
estimated payments Elevance Health discloses, by trigger · FY2025| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Death | $0 | $26,667,741 | $0 | $29,435,741 |
| Voluntary resignation | $0 | $17,027,265 | $0 | $19,795,265 |
| Change in control and involuntary termination | $15,120,000 | $26,667,741 | $162,000 | $45,201,369 |
| Disability | $0 | $26,667,741 | $0 | $29,435,741 |
| Involuntary termination without cause | $9,600,000 | $17,027,265 | $108,000 | $29,540,267 |
| Retirement | $0 | $17,027,265 | $0 | $19,795,265 |
Per the Potential Payments Upon Termination or Change in Control table in Elevance Health, Inc.'s FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.
Elevance Health’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Gail Boudreaux · this page | President and Chief Executive Officer | $22,582,314 |
| Mark Kaye | Executive Vice President and Chief Financial Officer | $7,992,077 |
| Peter Haytaian | Executive Vice President and President of Carelon and CarelonRx | $7,098,488 |
| Felicia Norwood | Executive Vice President and President of Government Health Benefits | $7,073,965 |
| C. Morgan Kendrick | Executive Vice President and President of Commercial and Specialty Health Benefits | $6,661,911 |
Board service
Elevance Health board · FY2021–FY2025How this board is paid
Company policy: Elevance Health pays directors a $125,000 cash retainer and $225,000 in DSUs. As stated in Elevance Health's FY2025 proxy.
The full Elevance Health compensation record
free company briefThis page is one person within Elevance Health's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Elevance Health proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Elevance Health's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Elevance Health's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order ELV
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.